The Horseracing Integrity Act and Safety Act (begins on page 2,980), which was signed into law on on December 28, 2020, focuses on ensuring the integrity of Thoroughbred horse racing and on the safety of Thoroughbred racehorses and jockeys by requiring national, uniform safety standards that include anti-doping and medication control and racetrack safety programs. An independent, self-regulatory authority will be empowered to implement and manage the safety standards and programs. The United States Anti-Doping Agency (USADA) will be tasked by the authority to oversee the medication control program. USADA manages the anti-doping programs for America’s Olympic athletes.
A blue-ribbon nominating committee was formed to select members of the board of directors of the HISA Authority as well as members of its two standing committees: Anti-doping and Medication Control, and Racetrack Safety. The nominating committee is seeking input on members of the board of directors of the HISA Authority as well as members of its two standing committees.
The board of directors will have nine members and the standing committees will have seven each. The board and committees will comprise individuals from outside the equine industry and persons with Thoroughbred industry experience and expertise
To recommend a nominee, please send your recommendation, including qualifications, to email@example.com